What did @lumi.skin actually say?
Honestly, the transcript is nearly impossible to parse. The audio appears to be severely garbled or auto-transcribed from Dutch into nonsense English, leaving us with phrases like "oxygen to take care of the water" and references to something called "Thorpe DaD." What we can work with is the caption, which makes two clear claims: rapid weight loss causes facial volume loss (sometimes called "Ozempic face"), and treatments like the Skin Infuzion System and something called SkinShot can address this through collagen stimulation and skin tightening.
The creator also implies these treatments are a safe solution. That framing, that a clinic device can reverse or meaningfully counteract GLP-1-related facial aging, is the claim worth scrutinizing. The science on facial volume loss after weight loss is real. The science on these specific devices reversing it is a much shorter conversation.
Does the science back this up?
The existence of "Ozempic face" is well-supported, even if the name is a marketing invention. Rapid weight loss, from any cause, depletes subcutaneous fat in the face, accelerating the appearance of skin laxity and volume loss. GLP-1 agonists simply make this more visible because they can drive significant weight loss quickly.
A 2023 study by Hwang et al. in Aesthetic Surgery Journal confirmed that facial fat loss correlates with rapid BMI reduction and is perceived as aging by observers. The mechanism involves loss of the buccal fat pad and periorbital fat, not purely skin elasticity. That distinction matters enormously for treatment planning.
On collagen stimulation devices: microneedling with radiofrequency (RF) has reasonable evidence for skin tightening. A 2022 review by Dayan et al. in Dermatologic Surgery found RF microneedling produced measurable improvements in skin laxity, though effect sizes were modest and most studies lacked long-term follow-up. The Skin Infuzion System specifically, which is a branded mesotherapy-adjacent device, has very limited independent peer-reviewed data. Most supporting evidence is manufacturer-funded or case-based.
What did they get wrong (or right)?
They got the underlying problem right. Facial volume loss after rapid weight loss is a real, documented phenomenon, and it does affect GLP-1 users disproportionately because the drugs work so well. Credit where it is due.
Where this falls apart is the implicit promise that skin infusion and collagen-boosting treatments can "safely fix" what is primarily a fat volume problem, not a collagen problem. Collagen stimulation addresses skin texture and mild laxity. It does not replace lost subcutaneous fat. For significant volume loss, the clinical literature points toward hyaluronic acid fillers or biostimulators like poly-L-lactic acid as more directly targeted interventions, per a 2023 consensus by Jones et al. in Journal of Cosmetic Dermatology.
Calling a branded device treatment a solution for Ozempic face without distinguishing between skin laxity and volume loss is misleading. It is not dangerous misinformation, but it sets patient expectations incorrectly, which matters when people are spending real money.
What should you actually know?
If you are losing weight on a GLP-1 medication and noticing facial changes, here is what the evidence actually supports. First, slower weight loss appears to reduce facial aging effects. A 2021 study by Sclafani et al. in JAMA Facial Plastic Surgery noted that gradual weight loss gave skin more time to contract. Second, not everyone on GLP-1 drugs will experience significant facial volume loss. Genetics, age, baseline body composition, and rate of weight loss all play roles.
Third, if you want to address it, consult a board-certified dermatologist or plastic surgeon, not a clinic marketing its own branded device as the answer. The treatment approach depends heavily on whether your issue is skin laxity, volume loss, or both. These require different interventions. Collagen stimulation devices may help with the former. They are unlikely to solve the latter.
Finally, be skeptical of any clinic that uses the phrase "Ozempic face" in marketing materials. It is a catchy term with legitimate scientific roots that has been rapidly co-opted to sell aesthetic treatments to a newly large patient population.